Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2
Abstract Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19). An appealing antiviral drug target is the coronavirus 3C-like protease (3CLpro) that is responsible for the processing of the viral polyproteins and liberation of f...
Guardado en:
Autores principales: | Juliana C. Ferreira, Wael M. Rabeh |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1fa90d8c4d1a4c508c78398e1dae072b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents
por: Vicky Mody, et al.
Publicado: (2021) -
POTENTIAL OF CURATELLA AMARICANA L. AGAINST SARS-COV2: BIOAVAILABILITY, MOLECULAR SIMILARITY AND MOLECULAR DOCKING BETWEEN SECONDARY METABOLITES AND PROTEASE TYPE 3-CHYMOTRYPSIN (3CLPRO)
por: Marcano,Emildo, et al.
Publicado: (2021) -
Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
por: Elisa Costanzi, et al.
Publicado: (2021) -
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
por: Wayne Vuong, et al.
Publicado: (2020) -
Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease
por: Alice Douangamath, et al.
Publicado: (2020)